Evidence map›Paper›PMID 42473920›Full record

ArticleACS nano2026

Manganese-Doped Carbon Nanodots as Next-Generation MRI and Fluorescence Imaging Agents.

Michele Cesco, Lydia Martínez-Parra, Samantha Marcelino Apresto, Cecilia Wetzl, Begoña Maria Echeverría-Beistegui, Jesús Ruiz-Cabello, Lucia Cardo, Maurizio Prato

Abstract read
In one paragraph

Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michele CescoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.
Lydia Martínez-ParraCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.
Samantha Marcelino AprestoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.
Cecilia WetzlCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.ORCID 0000-0002-5495-2141
Begoña Maria Echeverría-BeisteguiCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.
Jesús Ruiz-CabelloCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.ORCID 0000-0001-8681-5056
Lucia CardoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.ORCID 0000-0003-3387-9667
Maurizio PratoCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 194, Donostia-San Sebastián20014, Spain.ORCID 0000-0002-8869-8612

Funding

Agencia Estatal de Investigaci?n PID2021-123238OB-I00Agencia Estatal de Investigaci?n PID2022-140419OB-I00European Research Council ERC-AdG-2019, n. 885323Fundaci?n BBVA BIO_IMG_0008?la Caixa? Foundation HR20-00075Ministerio de Ciencia, Innovaci?n y Universidades PRE2020-095099NextGenerationEU PDC2021-121696-I00NextGenerationEU PID2021-123238OB-I00
6 · The paper itself

Abstract

Carbon nanodots (CNDs) have emerged as highly promising nanomaterials for biomedical applications due to their intrinsic fluorescence, excellent biocompatibility, and facile surface functionalization. Doping CNDs with paramagnetic metals, such as manganese (Mn), enables the development of dual-modal imaging probes that integrate magnetic resonance imaging (MRI) and fluorescence imaging (FI). Mn is a particularly attractive alternative to Gd-based contrast agents, offering lower toxicity, favorable paramagnetic properties, and physiological relevance. Here, we report a rapid microwave-assisted hydrothermal synthesis of Mn-doped carbon nanodots (MnCNDs) as dual-mode contrast agents for MRI and FI. A size exclusion chromatography purification step yielded a uniform population of MnCNDs containing 5% (w/w) Mn(II), characterized by excitation-dependent fluorescence emission and an amorphous carbon structure with a metal-enriched core. Importantly, MnCNDs exhibit a stable longitudinal relaxivity over 7 days, comparable to that of clinically used MRI contrast agents. Confocal fluorescence imaging confirmed efficient cellular uptake in vitro, while T1-weighted MRI in mice demonstrated their biocompatibility and strong potential as effective MRI contrast agents for in vivo applications. These findings position MnCNDs as robust and versatile nanoprobes for next-generation, multimodal bioimaging.

Indexed as

CarbonContrast MediaFluorescent DyesMagnetic Resonance ImagingManganeseOptical ImagingAnimalsCarbon Quantum DotsHumansMiceCarbonContrast MediaFluorescent DyesManganesecarbon nanodots (CNDs)manganese contrast agentsmanganese-doped nanoparticlesnanomedicinenanoprobes for biomedical imagingT1-weighted MRI

Identifiers

PMID42473920
PMCPMC13450473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.